Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010

Imagem de Miniatura
Arquivos
art_POLANCZYK_Research_Review_Epidemiological_modelling_of_attention_deficit_hyperactivity_2013.PDF (472.14 KB)
Citações na Scopus
151
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
ERSKINE, Holly E.
FERRARI, Alize J.
NELSON, Paul
FLAXMAN, Abraham D.
VOS, Theo
WHITEFORD, Harvey A.
SCOTT, James G.
Citação
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, v.54, n.12, p.1263-1274, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundThe most recent Global Burden of Disease Study (GBD 2010) is the first to include attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) for burden quantification. We present the epidemiological profiles of ADHD and CD across three time periods for 21 world regions. MethodsA systematic review of global epidemiology was conducted for each disorder (based on a literature search of the Medline, PsycInfo and EMBASE databases). A Bayesian metaregression tool was used to derive prevalence estimates by age and sex in three time periods (1990, 2005 and 2010) for 21 world regions including those with little or no data. Prior expert knowledge and covariates were applied to each model to adjust suboptimal data. Final prevalence output for ADHD were adjusted to reflect an equivalent value if studies had measured point prevalence using multiple informants while final prevalence output for CD were adjusted to reflect a value equivalent to CD only. ResultsPrevalence was pooled for males and females aged 5-19years with no difference found in global prevalence between the three time periods. Male prevalence of ADHD in 2010 was 2.2% (2.0-2.3) while female prevalence was 0.7% (0.6-0.7). Male prevalence of CD in 2010 was 3.6% (3.3-4.0) while female prevalence was 1.5% (1.4-1.7). ADHD and CD were estimated to be present worldwide with ADHD prevalence showing some regional variation while CD prevalence remained relatively consistent worldwide. ConclusionsWe present the first prevalence estimates of both ADHD and CD globally and for all world regions. Data were sparse with large parts of the world having no estimates of either disorder. Epidemiological studies are urgently needed in certain parts of the world. Our findings directly informed burden quantification for GBD 2010. As mental disorders gained increased recognition after the first GBD study in 1990, the inclusion of ADHD and CD in GBD 2010 ensures their importance will be recognized alongside other childhood disorders.
Palavras-chave
Global burden of disease study 2010, attention-deficit, hyperactivity disorder, conduct disorder, prevalence, statistical modelling
URI
https://observatorio.fm.usp.br/handle/OPI/5166
Referências
  1. Alyahri A, 2008, SOC PSYCH PSYCH EPID, V43, P224, DOI 10.1007/s00127-007-0293-x
  2. American Psychiatric Association, 2000, DIAGN STAT MAN MENT
  3. Canino G, 2010, SOC PSYCH PSYCH EPID, V45, P695, DOI 10.1007/s00127-010-0242-y
  4. Collett BR, 2003, J AM ACAD CHILD PSY, V42, P1015, DOI 10.1097/01.CHI.0000070245.24125.B6
  5. Ebejer J. L., 2012, PLOS ONE, V7
  6. Erskine H. E., 2013, J CHILD PSYCHOL PSYC
  7. Faraone Stephen V, 2003, World Psychiatry, V2, P104
  8. Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X
  9. Flaxman A. D., 2013, INTEGRATIVE METAREGR
  10. GBD, 2009, GBD STUDY OP MAN
  11. Granero R, 2008, EUR CHILD ADOLES PSY, V17, P352, DOI 10.1007/s00787-008-0677-9
  12. Hebrani P, 2007, ARCH IRAN MED, V10, P147
  13. KASMINI K, 1993, ACTA PSYCHIAT SCAND, V87, P253, DOI 10.1111/j.1600-0447.1993.tb03367.x
  14. Kessler RC, 2008, WHO WORLD MENTAL HLT
  15. Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271
  16. Laub JH, 2000, AM J PSYCHIAT, V157, P96
  17. McGrath JJ, 2009, SCHIZOPHRENIA BULL, V35, P577, DOI 10.1093/schbul/sbp004
  18. Milne BJ, 2009, AM J MED GENET B, V150B, P41, DOI 10.1002/ajmg.b.30764
  19. Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x
  20. Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036
  21. Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1
  22. Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
  23. Pajer KA, 1998, AM J PSYCHIAT, V155, P862
  24. Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
  25. Power TJ, 1998, PSYCHOL ASSESSMENT, V10, P250, DOI 10.1037/1040-3590.10.3.250
  26. Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
  27. Rowe R, 2010, J ABNORM PSYCHOL, V119, P726, DOI 10.1037/a0020798
  28. Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
  29. SIMON GE, 1995, EPIDEMIOL REV, V17, P221
  30. Skapinakis P, 2001, Epidemiol Psichiatr Soc, V10, P18
  31. Skounti M, 2007, EUR J PEDIATR, V166, P117, DOI 10.1007/s00431-006-0299-5
  32. Sourander A, 2009, ARCH GEN PSYCHIAT, V66, P398, DOI 10.1001/archgenpsychiatry.2009.21
  33. Susser E, 2010, PSYCHOL MED, V40, P895, DOI 10.1017/S0033291709991504
  34. United Nations, 2007, 202 UN ESAPWP DEP EC
  35. United Nations, 2011, WORLD POP PROSP 2010
  36. University of New South Wales, 2009, PROGR ILL DRUG US ME
  37. Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
  38. Wittchen HU, 2000, ACTA PSYCHIAT SCAND, V101, P2, DOI 10.1034/j.1600-0447.2000.101001002.x
  39. World Health Organization, 2008, GLOB BURD DIS 2004 U
  40. World Health Organization, 1992, ICD 10 CLASS MENT BE
  41. World Health Organization, 2008, MHGAP MENT HLTH GAP

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/21